Joel D Taurog Selected Research

HLA-B27 Antigen (HLA B27 Antigen)

1/2019	mTOR Blockade by Rapamycin in Spondyloarthritis: Impact on Inflammation and New Bone Formation in vitro and in vivo.
1/2017	Innate Immune Activation Can Trigger Experimental Spondyloarthritis in HLA-B27/Huβ2m Transgenic Rats.
1/2017	The Human Leukocyte Antigen (HLA)-B27 Peptidome in Vivo, in Spondyloarthritis-susceptible HLA-B27 Transgenic Rats and the Effect of Erap1 Deletion.
6/2015	Loss of bone strength in HLA-B27 transgenic rats is characterized by a high bone turnover and is mainly osteoclast-driven.
1/2014	HLA-B27 and human β2-microglobulin affect the gut microbiota of transgenic rats.
8/2012	Autoimmune epididymoorchitis is essential to the pathogenesis of male-specific spondylarthritis in HLA-B27-transgenic rats.
12/2010	The role of HLA-B27 in spondyloarthritis.
7/2009	Spondylarthritis in HLA-B27/human beta2-microglobulin-transgenic rats is not prevented by lack of CD8.
1/2009	Animal models of spondyloarthritis.
4/2006	Additional human beta2-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joel D Taurog Research Topics

Disease

7	Arthritis (Polyarthritis) 01/2019 - 01/2003
7	Ankylosing Spondylitis 01/2018 - 03/2004
5	Spondylitis 01/2019 - 04/2006
5	Inflammation (Inflammations) 01/2019 - 04/2006
4	Spondylarthritis (Spinal Arthritis) 10/2012 - 04/2006
2	Rheumatic Diseases (Rheumatism) 01/2018 - 01/2017
2	Colitis 04/2006 - 01/2003
1	Osteitis 01/2019
1	Tuberculosis (Tuberculoses) 01/2017
1	Bone Resorption 06/2015
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2015
1	Disease Progression 06/2015
1	Sacroiliitis 10/2014
1	Ankylosis 10/2014
1	Anterior Uveitis 01/2014
1	Psoriatic Arthritis 01/2014
1	Reactive Arthritis (Reiter Disease) 01/2014
1	Disease Susceptibility (Diathesis) 08/2005
1	Joint Diseases (Joint Disease) 03/2004
1	Thymoma (Thymic Carcinoma) 03/2004
1	Spondylarthropathies 01/2003

Drug/Important Bio-Agent (IBA)

13	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2019 - 01/2003
2	Interleukin-17 (Interleukin 17)IBA 01/2019 - 01/2019
1	Sirolimus (Rapamycin)FDA Link 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Biological ProductsIBA 01/2018
1	HLA-B Antigens (HLA-B)IBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	CytokinesIBA 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	AutoantibodiesIBA 10/2014
1	MagnesiumIBA 10/2014
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 10/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2012
1	AntigensIBA 01/2009
1	Cysteine (L-Cysteine)FDA Link 03/2004
1	CD8alphabeta antigenIBA 01/2003

Therapy/Procedure

1	Therapeutics 01/2019
1	Aftercare (After-Treatment) 10/2014
1	Castration 08/2012